Brie Carter - Author on Grafa

Kincora Copper (ASX:KCC) announced an expansion and the commencement of advanced geophysical exploration at its wholly owned Cowal East Project.

Global markets rallied on Monday after Donald Trump suggested the war with Iran could end soon, triggering a sharp drop in oil prices while stocks and cryptocurrencies moved higher.

ASX shed $138 billion in its worst day since 2025 as Middle East conflict drives oil prices higher and sparks global inflation fears.

Anthropic PBC filed two federal lawsuits Monday challenging the Pentagon’s decision to label the artificial intelligence startup a “supply chain risk,” an unprecedented move following the company’s refusal to permit unrestricted military use of its Claude chatbot.

Eltek (NASDAQ:ELTK), an Israeli manufacturer of technologically advanced printed circuit boards primarily serving defense, medical and industrial applications, on Monday reported full-year 2025 revenue of $51.8 million, an increase of 11% from the prior year.

YY Group Holding (NASDAQ:YYGH), a Singapore-based provider of on-demand staffing and integrated facility management services, on Monday released preliminary, unaudited financial results for the full year ended December 31, 2025, estimating revenue in the range of $57 million to $58 million, representing year-over-year growth of approximately 38.7% to 41.1%.

Editas Medicine (NASDAQ:EDIT) reported fourth-quarter results on Monday that significantly outpaced Wall Street projections, fueled by higher collaboration revenue and a sharp reduction in operating expenses.

Bristol Myers Squibb reached a major milestone in its next-generation protein degradation program on Monday, reporting that its oral CELMoD agent, mezigdomide, significantly extended the time patients lived without their cancer progressing in a pivotal Phase 3 study.

BETA Technologies reported a significant jump in full-year 2025 revenue following its market debut, as the electric aerospace pioneer scales its charging infrastructure and begins high-volume deliveries of its proprietary propulsion systems.

Agilent Technologies (NYSE:A) moved to significantly expand its clinical oncology presence on Monday, announcing an all-cash deal for Biocare Medical that adds a high-growth portfolio of cancer-staining antibodies and reagents.